A Platform Technology

NovaScan’s AI-enhanced spectral bioimpedance technology is a true platform, supporting multiple diagnostic and intraoperative oncology applications built on a shared hardware, software, and data foundation.

Several of these products have already been prototyped and evaluated in clinical trials. None of them are FDA cleared. A representative timeline indicating progress on a number of these initiatives is listed below.